Vetr Crowd Slowly Turning Positive On Kite Pharma, Now Rates It A Buy

By: via Benzinga
Shares of Kite Pharma Inc (NASDAQ: KITE) have been volatile this year, down 4.7 since January. Over the past three months, however, ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.